The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target
Author:
Affiliation:
1. Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Funder
National Natural Science Foundation of China
CAMS Innovation Fund for Medical Sciences
Publisher
Informa UK Limited
Subject
Cell Biology,Molecular Biology
Link
https://www.tandfonline.com/doi/pdf/10.1080/15548627.2019.1709762
Reference29 articles.
1. Hepatocellular carcinoma: a global view
2. Liver Transplantation
3. Surgery for malignant liver tumors
4. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
5. Sorafenib in treatment of patients with advanced hepatocellular carcinoma: a systematic review
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Substituted indole derivatives as UNC-51-like kinase 1 inhibitors: Design, synthesis and anti-hepatocellular carcinoma activity;Biomedicine & Pharmacotherapy;2024-09
2. Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation;Future Medicinal Chemistry;2024-08-15
3. Blockage of Autophagy for Cancer Therapy: A Comprehensive Review;International Journal of Molecular Sciences;2024-07-07
4. A novel chromone-based as a potential inhibitor of ULK1 that modulates autophagy and induces apoptosis in colon cancer;Future Medicinal Chemistry;2024-07
5. The mechanism of UNC-51-like kinase 1 and the applications of small molecule modulators in cancer treatment;European Journal of Medicinal Chemistry;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3